过去一年中添加的文章，按日期排序
[HTML][HTML] … pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer
51 天前 - … to prior afatinib, erlotinib and gefitinib treatment were 11.2 (95… and OS comparisons
between the chemotherapy-osimertinib … of osimertinib used in second-line therapy did not …
between the chemotherapy-osimertinib … of osimertinib used in second-line therapy did not …
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact …
G Pasello, M Lorenzi, D Scattolin, A Del Conte… - The …, 2024 - academic.oup.com
105 天前 - … ’ we considered effectiveness data on erlotinib and gefitinib… most frequent second-line
treatment was chemotherapy … in this study received second-line treatment in clinical trials, …
treatment was chemotherapy … in this study received second-line treatment in clinical trials, …